Neovascular glaucoma
MONDO:0019783Neovascular glaucoma is the most common type of secondary glaucoma, usually caused by diabetic retinopathy, central retinal vein occlusion and carotid artery obstruction but sometimes by trauma, uvietis or ocular tumors, and characterized by severe eye pain, synechial angle glaucoma, high intraocular pressure and leading to loss of vision.
15 clinical trials for this condition and its sub-types, 7 tagged with Neovascular glaucoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Can a simple office procedure ease glaucoma pressure?
Disease control Not yet recruitingThis study tests whether removing the ripcord from a glaucoma drainage device more than 3 months after placement lowers eye pressure. Adults with glaucoma who have had the ripcord in place for over 3 months will have it removed during a routine clinic visit. Researchers will meas…
Sponsor: Duke University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a tiny eye implant replace glaucoma drops?
Disease control Not yet recruitingThis trial tests a new device called VividFlo, a small implant placed under the eye's surface to help drain fluid and lower pressure in people with glaucoma. The study involves 10 adults with glaucoma in one eye, who will receive the implant during surgery. Researchers will track…
Sponsor: VividWhite Pty Ltd • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Which eye implant best tames glaucoma? a head-to-head trial aims to find out.
Disease control Not yet recruitingThis trial compares two surgical implants—the Baerveldt Glaucoma Implant and the Paul Glaucoma Implant—in people with glaucoma that is not well controlled by eye drops. Both devices are tiny tubes placed in the eye to drain fluid and lower pressure. The study will track which imp…
Phase 4 • Sponsor: University of Sydney • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC